Philippines FDA proposes huge fee hike to fulfil new obligations
This article was originally published in RAJ Devices
The Philippines Food and Drug Administration (formerly the Bureau of Food And Drugs), has proposed a substantial increase in the levels of fees it charges for various services, including the regulation of pharmaceuticals and medical devices1,2.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.